The Evaluatıon Of Ace, Ace Receptor Polymorphısms And Serum And Tıssue Levels Of Some Angıogenıc Markers In Glıoma


Thesis Type: Doctorate

Institution Of The Thesis: Gazi University, Sağlık Bilimleri Enstitüsü, Biyokimya (Ecz) Anabilim Dalı, Turkey

Approval Date: 2019

Thesis Language: Turkish

Student: TAYLAN TURAN

Supervisor: Aymelek Gönenç

Abstract:

Gliomas are the most common primary tumors of CNS. Despite the advance in the

elucidation of the molecular pathogenesis of these tumors, glioma still remains incurable.

ACE and AGTR1 polymorphism are the focal points for various cancer studies, both in

relation to cancer pathogenesis and its relationship with metastasis and angiogenesis. There

are many studies on the relationship between ACE and AGTR1 polymorphism and cancer

pathogenesis in various types of cancer in different populations. However, the results

obtained from these studies are in contradiction when compared to each other. In this

thesis, it was aimed to find out the possible connection between ACE, AGTR1

polymorphism and glioma pathogenesis and also the relationship between some angiogenic

markers which will be measured in both serum and tissue, and angiogenesis. 96 glioma

patients and 104 healthy controls with mean age 49,09±1,33 and 48,60±1,34 were included

in the study. ACE I/D, AGTR1 -168A/G, AGTR1 -535C/T, AGTR1 -825T/A, VEGF

+936C/T and VEGF -2578C/A polymorphisms were investigated in the thesis by PCRRFLP

method. By this means, allele and genotype frequencies between patients and

healthy controls were determined. Relative gene expressions of ACE, AGTR1 and VEGF

were determined by Real Time-PCR while, the levels of parameters that are associated

with angiogenesis such as ACE, VEGF, ET-1, eNOS and NO were measured in both

serum and tissue by using ELISA method. As a conclusion, in AGTR1 -168A/G

polymorphism, the risk of glioma of AA genotype decreased significantly, G allele

increased the risk of glioma by 2,27 times. Allele frequency and genotype distributions of

ACE I/D, AGTR1 -535C/T, -825T/A, VEGF +936C/T and VEGF -2578C/A

polymorphisms were found to be similar distribution between patient and control groups.

Serum ACE, VEGF, eNOS, NO and tissue ACE, ET-1, eNOS, NO values were also

significantly different between the patient and healthy control groups. ACE, AGTR1 and

VEGF gene expressions of the patient group were found to be significantly higher than the

control group. The presence of high tumor risk in G allele in AGTR1 polymorphism,

increased serum levels and gene expression of ACE in glioma shed light on the

development of tumor in terms of ACE and ACE receptor polymorphism.

Key Words : Glioma, Polymorphism, ACE, AGTR1, Angiogenesis, Real Time PCR